Search

everythinglearnresearchcommunity

for

Search:↓

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Finasteride cream reduces hair growth in women with hirsutism, but more research needed.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Combination therapy improves hair growth in advanced hair loss.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Smoking and drinking worsened hair loss in men with genetic hair loss, while eating and sleeping habits didn't; genetics played a bigger role than environment in hair loss.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Various treatments exist for hair loss, but more research is needed for better options.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Longer CAG repeats in gene linked to more severe hair loss in females.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.